Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines

Apr 10, 2014

FDA develops an assay that could speed the release of pandemic influenza vaccines.

uniQure Announces Management Changes

Apr 10, 2014

uniQure appoints a new COO and vice president, Medical affairs.

Fette Compacting America Appoints New President

Apr 10, 2014

Fette Compacting America appoints Sean Scully as its new president.

Aesica Consortium Wins Technology Strategy Board Grant

Apr 10, 2014

Aesica's consortium project receives grant to investigate an industrial biotechnology process to improve the manufacturing of an API.

Desktop Human Body Developed for Toxicity Testing

Apr 10, 2014

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

Dalton Pharma Completes Aseptic Filling Capabilities Expansion

Apr 7, 2014

Dalton Pharma completes its $2.5 million expansion in Toronto for sterile and aseptic filling capabilities.

Merck Announes Management Changes

Apr 7, 2014

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

FDA Approves Oralair to Treat Allergic Rhinitis

Apr 7, 2014

FDA approves Oralair, the first sublingual allergen extract for the treatment of pollen allergies.

ChemCon Passes its Fourth FDA Inspection

Apr 7, 2014

ChemCon passes its fourth FDA inspection in the 17-year history of the company.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here